NEWS RELEASE 16-MAY-2024 Charité study on effects of taking proton pump inhibitors (PPIs) on bone health in rheumatism patients Peer-Reviewed PublicationCHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN SYMBOLIC IMAGE: DRUG PACKAGES IN A PHARMACY © CHARITÉ | JANINE OSWALDCREDIT: © CHARITÉ | JANINE OSWALD Proton pump inhibitors (PPIs), a specific class of antacid drugs, are among the most widely...
AMERICAN COLLEGE OF RHEUMATOLOGY Research NewsSHARE PRINT E-MAIL ATLANTA — New research presented at ACR Convergence, the American College Rheumatology’s annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine within one year, and that transitioning patients to a potent antiresorptive drug can lead to even...
POSTED BY DAVID HILL-BUFFALO (Credit: Getty Images) Getting five or fewer hours of sleep a night is associated with low bone mineral density and higher odds of osteoporosis, researchers report. “Our study suggests that sleep may negatively impact bone health, adding to the list of the negative health impacts of poor sleep,” says lead author Heather...
New UC Davis Health studies help explain why one break can lead to others UNIVERSITY OF CALIFORNIA – DAVIS HEALTH SYSTEM Breaking a bone causes bone density losses throughout the body, not just close to the site of the fracture, and primarily around the time of the fracture, two new studies from UC Davis Health...
